picotamide has been researched along with aspirin in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 7 (38.89) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Liu, XJ; Wang, X; Wang, Y; Zhang, ZH | 1 |
| de Falco, FA; Mastroroberto, G; Montariello, A; Visconti, OS | 1 |
| Cattaneo, M; Lecchi, A; Mannucci, PM; Tenconi, PM | 1 |
| Alberti, P; Corona, C; Gresele, P; Nenci, GG | 1 |
| Feldhoff, CM; Gresele, P; Pieters, G; Vermylen, J | 1 |
| Alessandri, C; Balsano, F; Ghiselli, A; Iuliano, L; Praticò, D; Violi, F | 1 |
| Castiglioni, C; Gazzaniga, PP; Parisi, S; Pignatelli, P; Pulcinelli, FM; Riondino, S | 1 |
| Boddi, M; Gensini, GF; Gori, AM; Ieri, A; Margheri, M; Martini, F; Modesti, PA; Neri Serneri, GG; Poggesi, L; Rostagno, C | 1 |
| Ambrosio, G; Chiariello, M; Golino, P; Gresele, P; Leproux, GB; Pascucci, I; Ragni, M; Russolillo, E | 1 |
| Berrettini, M; De Cunto, M; Nenci, GG; Orzalesi, G; Romanelli, A; Volpato, I | 1 |
| Corsini, G; Milani, M; Vetrano, A | 1 |
| Ballerio, R; Buccellati, C; Casagrande, C; Ciceri, P; Folco, G; Nicosia, S | 1 |
| Gresele, P; Migliacci, R | 1 |
| Coccheri, S; Marubini, E; Neri Serneri, GG; Violi, F | 1 |
| Hiatt, WR; Krantz, MJ | 1 |
| Hackam, DG | 1 |
| Liu, XJ; Meng, X; Shi, TE; Wang, X; Wei, TT | 1 |
1 review(s) available for picotamide and aspirin
| Article | Year |
|---|---|
Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication.
Topics: Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Humans; Intermittent Claudication; Lower Extremity; Meta-Analysis as Topic; Peripheral Vascular Diseases; Phthalic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Ticlopidine | 2006 |
4 trial(s) available for picotamide and aspirin
| Article | Year |
|---|---|
[Clinical efficacy of picotamide].
Topics: Adult; Aged; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Phthalic Acids | 1991 |
The role of extraplatelet thromboxane A2 in unstable angina investigated with a dual thromboxane A2 inhibitor: importance of activated monocytes.
Topics: Aged; Angina Pectoris; Angina, Unstable; Aspirin; Double-Blind Method; Female; Follow-Up Studies; Humans; Leukocytes, Mononuclear; Lymphocytes; Male; Middle Aged; Myocardial Ischemia; Phthalic Acids; Placebos; Platelet Aggregation Inhibitors; Prospective Studies; Thromboxane A2 | 1994 |
Effects of aspirin or picotamide, an antithromboxane agent, in combination with low-intensity oral anticoagulation in patients with acute myocardial infarction: a controlled randomized pilot trial.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Phthalic Acids; Pilot Projects; Platelet Aggregation Inhibitors; Single-Blind Method; Thromboxanes | 1999 |
Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
Topics: Adult; Aged; Aspirin; Diabetic Angiopathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Peripheral Vascular Diseases; Phthalic Acids; Platelet Aggregation Inhibitors; Risk Factors; Survival Analysis; Thromboxane A2 | 2004 |
13 other study(ies) available for picotamide and aspirin
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Synthesis, in vitro cytotoxicity and biological evaluation of twenty novel 1,3-benzenedisulfonyl piperazines as antiplatelet agents.
Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Fibroblasts; Mice; Molecular Structure; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Structure-Activity Relationship | 2021 |
In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Arachidonic Acid; Aspirin; Blood Platelets; Collagen; Drug Interactions; Female; Humans; Male; Malondialdehyde; Phthalic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Sulfonamides; Thromboxane B2 | 1991 |
Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression.
Topics: Animals; Aspirin; Disease Models, Animal; Epoprostenol; Male; Mice; Phthalic Acids; Platelet Aggregation Inhibitors; Platelet Count; Pulmonary Embolism; Thromboxane B2 | 1990 |
Acetylsalicylic acid, BM 13.177 and picotamide improve the survival of endotoxin-infused rabbits.
Topics: Animals; Aspirin; Endotoxins; Female; Imidazoles; Male; Methylprednisolone; Phthalic Acids; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Shock, Septic; Sulfonamides; Thromboxane-A Synthase | 1988 |
Inhibition by picotamide of thromboxane production in vitro and ex vivo.
Topics: Adult; Aspirin; Blood Platelets; Female; Humans; In Vitro Techniques; Male; Phthalic Acids; Platelet Aggregation; Prostaglandins; Thromboxane A2; Thromboxane-A Synthase | 1988 |
Effect of picotamide on the calcium mobilization and phospholipase C activation in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Arachidonic Acid; Aspirin; Blood Platelets; Calcium; Chromatography, Gel; Enzyme Activation; Humans; In Vitro Techniques; Phthalic Acids; Platelet Activation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Receptors, Thromboxane; Thrombin; Thromboxane A2; Type C Phospholipases | 1994 |
The in vivo antiplatelet effects of thromboxane A2 synthase inhibitors are potentiated by simultaneous thromboxane A2/prostaglandin H2 receptor blockade.
Topics: Animals; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Drug Synergism; Epinephrine; Fatty Acids, Unsaturated; Female; Hydrazines; Imidazoles; Male; Phthalic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane-A Synthase | 1993 |
[In vitro study of the mechanism of the platelet anti-aggregant action of picotamide (G 137)].
Topics: Arachidonic Acid; Aspirin; Blood Platelets; Humans; Malondialdehyde; Molecular Structure; Phthalic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Structure-Activity Relationship; Thromboxane A2; Thromboxane-A Synthase | 1983 |
Evaluation of the effects of anti-thromboxane agents in platelet-vessel wall interaction.
Topics: Animals; Aorta, Thoracic; Arachidonic Acid; Aspirin; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cell Communication; Dinoprost; Endothelium, Vascular; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Male; Methacrylates; Muscle Tonus; Muscle, Smooth, Vascular; Phthalic Acids; Platelet Activation; Platelet Aggregation Inhibitors; Rabbits; Receptors, Thromboxane; Thromboxane A2; Thromboxane-A Synthase | 2002 |
Picotamide versus aspirin in diabetic patients with peripheral arterial disease: has David defeated Goliath?
Topics: Arteries; Aspirin; Diabetic Angiopathies; Humans; Peripheral Vascular Diseases; Phthalic Acids; Platelet Aggregation Inhibitors | 2004 |
Medical management of peripheral arterial disease.
Topics: Aspirin; Clopidogrel; Cost-Benefit Analysis; Humans; Peripheral Vascular Diseases; Phthalic Acids; Platelet Aggregation Inhibitors; Ticlopidine | 2006 |
Synthesis and the Evaluations in vitro Antiplatelet Aggregation Activities of 4-Ethoxyisophthalamides.
Topics: Aspirin; Drug Design; Humans; Inhibitory Concentration 50; Phthalic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Quantitative Structure-Activity Relationship; Structure-Activity Relationship | 2015 |